The FDA has once again been caught red-handed ignoring the dangers of a widely-prescribed drug and compromising the health of millions. Internal email messages have now surfaced about how the FDA pushed the antibiotic drug Ketek despite urgent warnings from its senior drug safety scientists. The details of this scandal further highlight the dubious operations of the Food and Drug Administration, which consistently places the profits of drug companies as a higher priority than public health.
Ketek was approved under suspicious circumstances in the first place. A key clinical trial for the drug, involving 24,000 patients, was repeatedly found to be fraudulent, according to FDA investigators. One FDA document concluded that Sanofi-Aventis hid safety dangers from the FDA -- dangers the FDA later discovered on its own.
One FDA safety scientist, Dr. Cooper, wrote, “I tried to argue that given Aventis’s track record in which they have proven themselves to be nontrustworthy that we have to consider the possibility that they are intentionally doing a poor job of collecting the postmarketing data to protect their drug sales.”
Dr. David Graham added, “For F.D.A. to refer to its being reassured by postmarketing data from Latin America and Europe as a basis for declaring ‘Ketek is safe’ is in my opinion a great abuse of such surveillance data.”
Yet the drug was approved anyway, and the FDA now cites a known fraudulent study to defend the drug and argue against its withdrawal.
Four FDA safety officials (Dr. Charles Cooper, Dr. David Ross, Dr. Rosemary Johann-Liang and Dr. David Graham) ultimately sounded the alarm over Ketek's safety in internal emails. As now seems routine at the FDA, they were ignored. (See The Rise and Fall of Rezulin to see another such example.)
A drug that can kill
More than five million prescriptions have been written for
Ketek since its approval in the
United States. Ketek can cause loss of consciousness, blurred vision, and in rare circumstances, even death. It has so far been linked to
liver failure in fourteen adults, four of which have died. Twenty-three more suffered serious liver injury. Given that the reporting of drug side effects remains voluntary in the United States, it is possible that the actual number of people harmed by Ketek is ten to twenty times larger.
Senior FDA drug safety scientist Dr. David Graham -- best known for blowing the whistle on Vioxx -- is now recommending that the agency pull Ketek from shelves. The drug, Dr. Graham explains, is at least as toxic to the liver as three other drugs that have been pulled by the FDA. Furthermore, the FDA's original approval of the drug was based on a safety study that FDA officials knew was fraudulent.
The FDA's approval of Ketek, Dr. Graham wrote in a June 16 email, was a mistake. “It’s as if every principle governing the review and approval of new drugs was abandoned or suspended where telithromycin [Ketek] is concerned,” he wrote. “We don’t really know if the drug works; no one is claiming it works better than other, safer drugs; and we’re flying blind as far as safety goes, except for our own A.D.R. data that suggests telithromycin is uniquely more toxic than most other drugs." He concluded by recommending the drug be withdrawn.
In response, Aventis, the company that manufactures Ketek, announced it was adding a warning to the drug's label. It's the standard response of drug companies and FDA officials to any dangerous drug: Slap a warning label on the drug and call it "safe enough." Warning labels, however, don't make drugs any safer. They only provide a justification for the continued promotion of drugs that even some of the FDA's own scientists believe should be withdrawn from the marketplace.
“It’s no surprise to learn that the F.D.A. didn’t listen to Dr. Graham on the dangers of Ketek,” said Sen. Charles Grassley. “The F.D.A. has made it their business to discredit Dr. Graham and others who aren’t willing to cater to the drug companies.”
Sen. Grassley is a frequent observer and critic of FDA activity, and has worked on legislation to reform the agency.
How long will FDA fraud be allowed to continue?
While Ketek in no way appears to be more dangerous than drugs like Rezulin or Vioxx, its approval and defense within the FDA serves as yet another example of FDA officials covering their eyes and refusing to see the dangers of the drug when there's so much money to be made from selling it. Pleasing
Big Pharma is unquestionably the FDA's top priority these days, and any idea of actually protecting the public remains a distant memory.
The FDA not only routinely approves and defends dangerous prescription drugs (much to the delight of drug companies), it also goes out of its way to discredit and outlaw nutritional supplements, herbal medicine and anything tied to alternative medicine (also much to the delight of drug companies). Rather than regulating Big Pharma, the FDA has now become its greatest promoter.
The FDA's power is based on censorship and intimidation, not education and empowerment. On numerous occasions, the agency has attempted to censor and / or intimidate its own scientists, including Dr. David Graham who was nearly silenced before he could testify to Congress about the dangers of Vioxx.
The greatest threat to our safety isn't terrorism
As I have stated many times, I believe the
Food and Drug Administration is currently the greatest threat to the
health and safety of the
American people, far outweighing the threat of terrorism or violent crime. Over one hundred thousand Americans are killed each year by FDA-approved prescription drugs, and well over two million are harmed. Each year, FDA-approved drugs kill more Americans than died in the Vietnam War plus the 9/11 terrorism events combined.
Yet astonishingly, the FDA believes that too much information about the dangers of drugs is being communicated to the public by drug safety officials like Dr. David Graham. If the FDA had its way, all such information would be permanently censored, the public would never be warned about drug dangers, and, in fact, the public would be denied the right to sue drug companies for harm caused by FDA-approved prescription drugs.
The Ketek fiasco is merely the latest in a long history of FDA negligence and fraud that makes the agency a genuine threat to the health and safety of the American people.
About the author: Mike Adams is a natural health researcher, author and award-winning journalist with a mission to teach personal and planetary health to the public He has authored more than 1,800 articles and dozens of reports, guides and interviews on natural health topics, impacting the lives of millions of readers around the world who are experiencing phenomenal health benefits from reading his articles. Adams is a trusted, independent journalist who receives no money or promotional fees whatsoever to write about other companies' products. In mid 2010, Adams produced NaturalNews.TV, a natural health video sharing website offering user-generated videos on nutrition, green living, fitness and more. He also founded an environmentally-friendly online retailer called BetterLifeGoods.com that uses retail profits to help support consumer advocacy programs. He's also a successful software entrepreneur, having founded a well known email marketing software company whose technology currently powers the NaturalNews email newsletters. Adams is currently the executive director of the Consumer Wellness Center, a 501(c)3 non-profit, and practices nature photography, Capoeira, martial arts and organic gardening. He's also author of numerous health books published by Truth Publishing and is the creator of several consumer-oriented grassroots campaigns, including the Spam. Don't Buy It! campaign, and the free downloadable Honest Food Guide. He also created the free reference sites HerbReference.com and HealingFoodReference.com. Adams believes in free speech, free access to nutritional supplements and the ending of corporate control over medicines, genes and seeds. Known on the 'net as 'the Health Ranger,' Adams shares his ethics, mission statements and personal health statistics at www.HealthRanger.org
Have comments on this article? Post them here:
people have commented on this article.
Wednesday, July 19, 2006
Email this article to a friend
Share this article on: 
Now Available from 
